Subscribe to Updates in Financial & Business Services

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Fund Services Experts

Articles with lock require a subscription to GLG News | Request a free trial
March 17, 2008
Consolidation among Dealers is a Negative for OTC Derivatives Brokerage
Analysis of: JP Morgan Pays $2 a Share for Bear Stearns | www.nytimes.com
Author: GLG Expert Contributor
Inter-dealer broker revenue is vulnerable to the quantity of dealers that are available.  Lower valuation of book value of investment banks as a result of the Bear Stearns acquisition by JP Morgan may increase consolidation among primary dealers of OTC derivatives. This will result in lower...
January 4, 2008
Recent lawsuits over inappropriate investments will result in lower risk tolerance for asset managers.
Analysis of: State Street Corp. Is Sued Over Pension Fund Losses | www.nytimes.com
Author: GLG Expert Contributor
1) Lawsuits over "breach of fiduciary duty" will open the door to the legal system making a determination as to the appropriate riskiness of assets. 2) Money managers will give pause when looking at investing in complex financial structures (ex. CDO's) for fear they could be sued. 3)...
October 23, 2007
Lessons to Be Learned: Farewell to Exubera
Analysis of: Pfizer Abandons Exubera, Posts 77% Earnings Decline | online.wsj.com
Author: GLG Expert Contributor
There remains a very important message to be learned from from Pfizer closing  the doors on Exubera: physicians and other prescribers are not yet  ready to embrace inhaled insulin.  Despite the clinical results that  Big Pharma may present, many health care professionals are incredibly...
October 9, 2007
Credit Derivative Swap trading is ready to move to an exchange for the benefit of all participants.
Analysis of: Interview with NYSE CEO John Thain | www.gartner.com
Author: GLG Expert Contributor
With global exchanges looking to expand their product offerings and dealers looking to increase prime brokerage revenue, an opportunity exists to create an exchange based Over-the-Counter derivatives market.

Page : 11 to 4 of 4

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-02T17:45:17.163